Multiple indirect pathways

The term "Multiple indirect pathways" is a descriptive phrase rather than a specific molecular target, receptor, or enzyme. In biological and pharmacological literature, it typically refers to complex signaling circuits, such as the indirect pathway of the basal ganglia which involves a multi-synaptic sequence regulating motor control (Purves et al., 2001). It may also describe the indirect mechanism of action of certain drugs that influence a physiological outcome through intermediary molecules or secondary signaling cascades rather than direct binding to a primary effector (Goodman & Gilman, 2017). Because this term encompasses a broad range of non-specific biological interactions and systemic processes, it cannot be classified as a discrete therapeutic target. As such, it does not possess a unique molecular structure, specific interacting ligands, or standardized biomarkers for clinical monitoring. In the context of drug discovery, targeting "multiple indirect pathways" usually implies a polypharmacological approach or a systemic intervention rather than a precision medicine strategy aimed at a single protein. Consequently, this entry is considered incorrect as a standalone molecular target.

Other names

Indirect pathway of the basal gangliaIndirect signaling mechanismsSecondary signaling cascades

Modulation of downstream signaling or multi-synaptic circuits rather than direct molecular binding to a single target.